Categories
-
Wal-Mart
- General Motors
- Dow Jones
- Goldman Sachs
- Accor
- Renault
- Reuters
- BNP Paribas
- Toyota
- AgBank
- Microsoft
- Intel
- ALCATEL-LUCENT
- AXA
- Japan Airlines
- Agricultural Bank of China
- Lucien Barri
- CITIGROUP
- toutes nos catégories
Tags
Catégorie - Bayer
BrightScope Releases the 2009 Top 30 401k Plans ListLockheed Martin, Southwest Airlines, IBM, FedEx, Bayer, and Chevron Are Among the Top 401k Plans in BrightScope's First Year-End Ratings List
2009-12-08 - Marketwire
Bayer must pay $1.5M to AK, MS rice farmersA jury on Friday decided in favor of U.S. and European shareholders who said the Paris-based Vivendi media group lied to the public about its shaky finances, setting the stage for the possible distrib...
2010-02-07 - MalaysiaNews.net
La Bourse de Francfort dans le vert, mais Bayer souffre après ses ...La Bourse de Francfort était dans le vert vendredi matin, mais le groupe de chimie et de pharmacie Bayer souffrait après des résultats jugés décevants. ...
2010-02-26 - Le Point
BOURSE/Francfort: le Dax (+1,2%) termine dans le vert malgré Bayer ...Francfort (awp/afp) - La Bourse de Francfort a terminé nettement dans le vert vendredi, mais Volkswagen et Bayer ont bu la tasse après des résultats très en ...
2010-02-26 - Romandie.com
Bayer déçoit le marché avec ses résultatsLe groupe allemand de chimie et de pharmacie a fait état d'un bénéfice net en hausse de 44% au quatrième trimestre mais qui ressort nettement en dessous des attentes. En Bourse ...
2010-02-26 - La Tribune
Bayer Settles With Novartis Over Hemophilia-Treatment PatentSeparately, Novartis sued Wyeth claiming infringement of two patents. Wyeth, now owned by Pfizer Inc., wasn't part of this accord. ...
2010-03-04 - BusinessWeek
With Artificial Muscle, Bayer strengthens its E/E offeringsResearch on electro-activated polymers that began at Stanford University, and was further developed at a company called Artificial Muscle Inc., has now been acquired by Bayer MaterialScience. The acquisition of the company, its patents, and its patent applications is the latest purchase by the massive plastics and chemicals supplier to focus on plastic film's surface haptics and appearance. read ...
2010-03-09 - PlasticsToday.com
24.03.2010 - DJ DGAP-PVR: Bayer Aktiengesellschaft: Release according to Article 26, Section 1 of the WpHG [the German ...Dissemination of a Voting Rights announcement, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement.
2010-03-24 - 4investors
Bundesliga: Schalke passe devant le BayernBERLIN (Reuters) - Un doublé de Kevin Kuranyi a permis samedi à Schalke 04 de s'installer aux commandes de la Bundesliga grâce à un succès 2-0 sur le terrain du Bayer ...
2010-03-27 - Challenges
Bayer still out to buy, not sell, vet businessesBayer last year tried to bolster the unit but failed to snatch up animal health businesses that were offered as part of Wyeth's merger with Pfizer (PFE. ...
2010-03-26 - Reuters
DJ DGAP-PVR: Bayer Aktiengesellschaft: Release according to Article 26, Section 1 of the WpHG [the German Securities ...Bayer Aktiengesellschaft / Release of an announcement according to Article 21, Section 1 of the WpHG [the German Securities Trading Act] (share) 08.04.2010 12:00 Dissemination of a Voting Rights announcement, transmitted by DGAP - a company of EquityStory AG.
2010-04-08 - Financial.de
Bayer tells its side at rice contamination trialAttorneys for Bayer Cropscience began their response Thursday to almost seven days of testimony and evidence presented by a group of 12 Lonoke County rice farmers and partnerships. The Lonoke County farmers are seeking reparation for damages they claim they suffered when genetic material from a strain of rice under development by Bayer was found in the commercial rice crop.
2010-04-17 - The Lonoke Democrat
Pfizer ends trial of Sutent in liver cancerPfizer Inc. said Thursday it stopped a late-stage clinical study of its drug Sutent as a treatment for liver cancer. Pfizer said patients who were treated with Sutent were not surviving as long as patients who were treated with another drug, Bayer Healthcare'... Pfizer - Clinical trial - Cancer - Health - Sutent
2010-04-23 - San Francisco Chronicle
Bayer rate le consensus au 1er trimestre, relève ses ...Bayer a fait état de performances trimestrielles légèrement en deçà des attentes tout en relevant ses prévisions pour l'ensemble de 2010, la reprise de l'activité de ses ...
2010-04-29 - L'Expansion
Les grands industriels européens commencent à croire en une nette ...Pernod Ricard, Siemens, AstraZeneca et Bayer ont relevé hier leurs prévisions de profits. Dans de nombreux groupes, le début d'année se passe mieux que prévu. Un mouvement ...
2010-05-01 - Les Echos
Bayer Selects Vision Chain as Enterprise Demand Signal RepositoryVision Chain, Inc. ( www.visionchain.com ), the leading global provider of demand signal repository and predictive analytic solutions, announced today that Bayer Healthcare LLC, the global leader in trusted brands for healthcare and nutrition, has licensed its technology platform to analyze store-specific sales, assortments, prices, promotions and other factors to ...
2010-05-25 - SYS-CON Media
Bayer, HP, Nissan, Unilever, Nissan: Intellectual PropertyUnilever Plc, the London-based maker of Slim-Fast, Hellman's mayonnaise, Dove soap and Lipton tea, sent three Brooklyn, New York, entrepreneurs a ...
2010-06-02 - BusinessWeek
Biogen Idec Inc : Biogen poursuit Pfizer, Bayer pour ...NEW YORK (Dow Jones)--Le groupe de biotechnologies Biogen Idec Inc. (BIIB) a porté plainte contre plusieurs sociétés pharmaceutiques, affirmant que leurs traitements de la ...
2010-06-02 - Investir
Bayer, HP, Nissan, Unilever: Intellectual PropertyUnilever Plc, the London-based maker of Slim-Fast, Hellman's mayonnaise, Dove soap and Lipton tea, sent three Brooklyn, New York, entrepreneurs a ...
2010-06-02 - BusinessWeek
La Bourse de Francfort finit en confiance, Bayer n'en profite qu'à ...La Bourse de Francfort a fini en hausse lundi, soutenue par Wall Street et un regain de confiance sur la reprise mondiale qui a fait s'apprécier l'euro face ...
2010-06-14 - Le Point
La chimie poursuit ses lourds investissementsS'il existe une preuve de la bonne santé de la chimie dans la région, c'est bien le montant de ses investissements. Ainsi après ceux de Toray, Rhodia ou encore Bayer Cropscience ...
2010-06-26 - Le Progrès
La chimie poursuit ses lourds investissements en Rhône ...S'il existe une preuve de la bonne santé de la chimie dans la région, c'est bien le montant de ses investissements. Ainsi après ceux de Toray, Rhodia ou encore Bayer Cropscience ...
2010-06-26 - Le Progrès
Biogen Idec Names George Scangos CEOExelixis CEO and Bayer's Former President of Biotechnology Brings Strong Scientific Expertise and De...
2010-06-30 - citybizlist Boston
Biogen Idec nomme George Scangos au poste de Président ...PDG d’Exelixis et anciennement Président de Bayer Biotechnology, il apporte une solide expertise scientifique et une vaste expérience des secteurs de la biotechnologie et de la ...
2010-07-01 - Business Wire
Gilead, Bayer & Genzyme sue Lupin for alleged Para IV patent infringements in USThe Mumbai-based Lupin Ltd and its US subsidiary, Lupin Pharmaceuticals Inc, have been sued by at least three firms in United States at various courts in the nation, within a week starting from July 14, for Para IV patent infringement allegedly by the former attempting to manufacture and sell generic version of products before expiry of patent protection, according to reports.
2010-07-27 - PharmaBiz
Barclays, Apple, Nokia, Wachovia, Bayer's Trasylol Settlement: Court NewsRobert Moffat, the former International Business Machines Corp. executive who pleaded guilty in the Galleon Group LLC insider-trading scheme, said accused tipster Danielle Chiesi “played him” to obtain tips.
2010-08-18 - Bloomberg
Battle of anticoagulants to dominate heart meetingLONDON, Aug 24 — Rival anti-clotting pills being developed by Bayer and Bristol-Myers Squibb are both set to show positive results next week as the race intensifies to replace the old, problematic heart drug warfarin. At stake is a potential new market estimated at more than US$10 billion (RM31.2 billion) a year — and possibly as much as US$20 ...
2010-08-24 - The Malaysian Insider
Bayer, Bristol intensify battle for $20 bn anticoagulant marketBayer, Bristol intensify battle for $20 bn anticoagulant marketBayer, Bristol intensify battle for $20 bn anticoagulant market
2010-08-24 - The Economic Times
PREVIEW - Battle of anticoagulants to dominate heart meetingLONDON (Reuters) - Rival anti-clotting pills being developed by Bayer and Bristol-Myers Squibb are both set to show positive results next week as the race intensifies to replace the old, problematic heart drug warfarin.
2010-08-24 - The Star
Pfizer, Bayer Fight to Replace Rat Poison in Stroke-Drug MarketBoehringer Ingelheim GmbH may be the first drugmaker to win U.S. approval of a revolutionary alternative for preventing strokes. It likely won’t be the last.
2010-08-29 - BusinessWeek
La Bourse de Francfort mal partie (-0,92%), Bayer détonneLa Bourse de Francfort partait en nette baisse mardi en matinée, à l'exception de Bayer, dans le sillage d'une faiblesse généralisée des Bourses asiatiques ...
2010-08-31 - Le Point
Bayer and Bristol's rival clot drugs both impressSTOCKHOLM (Reuters) - Rival anti-clotting drugs from Bayer and Bristol-Myers Squibb both impressed in clinical trials, keeping them firmly in the race to displace the old, problematic heart drug warfarin.
2010-08-31 - Reuters
Rival clot drugs both poised to replaced problematic WarfarinBoth Bristol’s apixaban and Bayer’s Xarelto are racing to replace old, difficult-to-use anti-clotting drug, warfarin
2010-09-01 - Toronto Star
An outgunned FDA tries to get tough with drug adsBy Susan Heavey and Lisa Richwine SPECIAL REPORT (SILVER SPRING, MARYLAND): It wasn't what you would call a casual get-together. In February 2009, a popular New York blogger attended a brunch with fellow "frazzled moms". They took in tips from a style expert and listened to a nurse extol the virtues of Mirena, a birth control device sold by Bayer Healthcare. The nurse was on Bayer's payroll. In ...
2010-09-03 - Free Malaysia Today
Drugmakers script social media to push medsIt wasn't what you would call a casual get-together. A popular New York blogger attended a brunch with fellow "frazzled moms." They took in tips from a style expert and listened to a nurse extol the virtues of Mirena, a birth control device sold by Bayer Healthcare. The nurse was on Bayer's payroll. birthcontrol - Bayer - Social media - New York City - Health
2010-09-03 - MSNBC
Sanofi veut prendre la tête dans le traitement du ...Le marché mondial de l'insuline représente dix milliards d'euros et celui du BGM, sur lequel sont présents des sociétés comme Abbott Laboratories, Roche et Bayer, six ...
2010-09-10 - Boursorama
Bayer's Betaferon Extends Multiple Sclerosis Patients' Lives, Study FindsBayer AG ’s betaferon multiple sclerosis treatment helped patients live longer when taken soon after the onset of the disease in a study researchers said is the first to show such a drug extends patients’ lives.
2010-10-15 - Bloomberg
Bayer launches unique fitness program for hemophilia A childrenBayer HealthCare is introducing a fitness program to help children ages 7-12 and young adults ages 13-16 with hemophilia A live active lives. "Living Fit! A Joint Effort" is a unique strength training, fitness and wellness program created to increase awareness of the importance of exercise and nutrition among this population and their caregivers.
2010-10-27 - News-Medical-Net
Le Dax dans le vert après une série de résultats (Dax +0,43%)La Bourse de Francfort évoluait en hausse jeudi matin, accueillant plutôt favorablement les résultats de Bayer et Lufthansa, mais sanctionnant MAN et BASF. ...
2010-10-28 - Le Point
Bourse de Francfort: le Dax en hausse (+0,60%), Bayer demandéLa Bourse de Francfort était bien orientée lundi en matinée, grâce en particulier à une hausse de Bayer et des valeurs automobiles. ...
2010-11-01 - Le Point
Bourse:Bayer salué, étude sur le XareltoL'action Bayer fait partie lundi des plus fortes hausses à la Bourse de Francfort après que les résultats d'une étude préliminaire ont amélioré les chances ...
2010-11-01 - Le Figaro
Bourse-Bayer grimpe après une étude préliminaire ...FRANCFORT, 1er novembre (Reuters) - L'action Bayer (BAYGn.DE: Cotation ) fait partie lundi des plus fortes hausses à la Bourse de Francfort après que les résultats d'une ...
2010-11-01 - Reuters France